Compugen (CGEN) SVP Sharon Kredo Russo Receives RSUs and Options

What Happened

• Sharon Kredo Russo, Senior Vice President, Research & Discovery at Compugen Ltd (CGEN), received two equity awards on July 29, 2026: 18,000 restricted stock units (RSUs) and a derivative option award for 24,000 shares. Both awards were granted at $0.00 (no cash paid) and therefore show $0 immediate purchase value.
• The awards are subject to time-based vesting: 25% vests on September 30, 2027, with the remaining 75% vesting in 12 equal quarterly installments thereafter, contingent on continued service.

Key Details

• Transaction date: 2026-07-29; Form 4 filed 2026-07-30 (timely filing).
• Grant prices: $0.00 for both the 18,000 RSUs and the 24,000 derivative/option award (no cash outlay).
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes: F1 = RSU award with 25% vesting on 9/30/2027, remainder in 12 equal quarterly installments. F2 = option award with same 25% + 12-quarter vesting schedule.
• No 10b5-1 plan, tax-withholding sale, or late-filing indication noted in the filing.

Context

• These grants are compensation awards, not open-market purchases or sales; they vest over time and therefore are meant to retain the executive rather than reflect immediate market conviction.
• The derivative award appears to be option-like (per footnote) and vests on the same schedule as the RSUs; neither award was exercised or sold at grant.